IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CONSTANCE A STOEHR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1851579635
CMS profile
1381753
Location
CLOVIS, CA

General Payments · PY2018–2024

$7,552.70

  • Reported across 247 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$3,765.91

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology CA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,440.00 1
Food and Beverage $1,252.14 36
Long term medical supply or device loan $898.78 10
Education $174.99 2

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $1,582.81 5
NOVARTIS PHARMACEUTICALS CORPORATION $898.78 10
Acerta Pharma LLC $371.43 10
E.R. Squibb & Sons, L.L.C. $311.25 9
SOBI, INC $224.60 4
EMD Serono, Inc. $117.59 1
Daiichi Sankyo Inc. $87.40 4
Adaptive Biotechnologies Corporation $61.37 2
Lilly USA, LLC $59.97 2
Celgene Corporation $25.76 1
Mirati Therapeutics, Inc. $24.95 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $886.28 47
PY2019 $1,298.63 106
PY2020 $368.46 17
PY2021 $40.43 2
PY2022 $480.89 7
PY2023 $712.10 19
PY2024 $3,765.91 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Adaptive Biotechnologies Corporation $30.43 04/30/2024 Food and Beverage Undisputed 01/23/2026 1150260274 CMS
Adaptive Biotechnologies Corporation $30.94 04/30/2024 Food and Beverage Undisputed 01/23/2026 1150260276 CMS
AstraZeneca Pharmaceuticals LP $23.79 01/29/2024 Food and Beverage Undisputed 01/23/2026 1104298620 CMS
AstraZeneca Pharmaceuticals LP $25.31 02/28/2024 Food and Beverage Undisputed 01/23/2026 1105519623 CMS
AstraZeneca Pharmaceuticals LP $103.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104245931 CMS
AstraZeneca Pharmaceuticals LP $14.45 06/06/2024 Food and Beverage Undisputed 01/23/2026 1105605719 CMS
AstraZeneca Pharmaceuticals LP $15.14 07/09/2024 Food and Beverage Undisputed 01/23/2026 1104392309 CMS
AstraZeneca Pharmaceuticals LP $105.03 07/25/2024 Food and Beverage Undisputed 01/23/2026 1104727083 CMS
AstraZeneca Pharmaceuticals LP $26.02 08/27/2024 Food and Beverage Undisputed 01/23/2026 1104652045 CMS
AstraZeneca Pharmaceuticals LP $20.61 09/10/2024 Food and Beverage Undisputed 01/23/2026 1105440553 CMS
AstraZeneca Pharmaceuticals LP $18.37 10/04/2024 Food and Beverage Undisputed 01/23/2026 1105644754 CMS
AstraZeneca Pharmaceuticals LP $19.71 12/17/2024 Food and Beverage Undisputed 01/23/2026 1104439231 CMS
Celgene Corporation $25.76 08/07/2024 Food and Beverage Undisputed 01/23/2026 1101189839 CMS
Daiichi Sankyo Inc. $21.95 05/23/2024 Food and Beverage Undisputed 01/23/2026 1089486994 CMS
Daiichi Sankyo Inc. $27.46 06/24/2024 Food and Beverage Undisputed 01/23/2026 1089486996 CMS
Daiichi Sankyo Inc. $17.09 07/18/2024 Food and Beverage Undisputed 01/23/2026 1089486998 CMS
Daiichi Sankyo Inc. $20.90 10/22/2024 Food and Beverage Undisputed 01/23/2026 1089486992 CMS
E.R. Squibb & Sons, L.L.C. $16.80 04/23/2024 Food and Beverage Undisputed 01/23/2026 1101809554 CMS
E.R. Squibb & Sons, L.L.C. $132.61 06/04/2024 Food and Beverage Undisputed 01/23/2026 1101809576 CMS
E.R. Squibb & Sons, L.L.C. $9.96 06/25/2024 Food and Beverage Undisputed 01/23/2026 1101809573 CMS
E.R. Squibb & Sons, L.L.C. $18.13 07/02/2024 Food and Beverage Undisputed 01/23/2026 1101809569 CMS
E.R. Squibb & Sons, L.L.C. $14.53 07/24/2024 Food and Beverage Undisputed 01/23/2026 1101809580 CMS
E.R. Squibb & Sons, L.L.C. $3.73 10/03/2024 Food and Beverage Undisputed 01/23/2026 1101809609 CMS
E.R. Squibb & Sons, L.L.C. $6.59 10/03/2024 Food and Beverage Undisputed 01/23/2026 1101809613 CMS
E.R. Squibb & Sons, L.L.C. $88.88 10/14/2024 Food and Beverage Undisputed 01/23/2026 1101809636 CMS
E.R. Squibb & Sons, L.L.C. $20.02 11/14/2024 Food and Beverage Undisputed 01/23/2026 1101809632 CMS
EMD Serono, Inc. $117.59 08/29/2024 Food and Beverage Undisputed 01/23/2026 1120274892 CMS
Lilly USA, LLC $29.94 05/29/2024 Food and Beverage Undisputed 01/23/2026 1136101874 CMS
Lilly USA, LLC $30.03 09/19/2024 Food and Beverage Undisputed 01/23/2026 1136101876 CMS
Mirati Therapeutics, Inc. $24.95 09/04/2024 Food and Beverage Undisputed 01/23/2026 1117177548 CMS
Novartis Pharmaceuticals Corporation $83.33 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269517 CMS
Novartis Pharmaceuticals Corporation $83.33 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269519 CMS
Novartis Pharmaceuticals Corporation $83.33 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269521 CMS
Novartis Pharmaceuticals Corporation $83.33 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269523 CMS
Novartis Pharmaceuticals Corporation $83.33 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269525 CMS
Novartis Pharmaceuticals Corporation $83.33 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269527 CMS
Novartis Pharmaceuticals Corporation $99.70 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269515 CMS
Novartis Pharmaceuticals Corporation $99.70 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269531 CMS
Novartis Pharmaceuticals Corporation $99.70 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269529 CMS
Novartis Pharmaceuticals Corporation $99.70 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1087269537 CMS
PFIZER INC. $23.41 02/19/2024 Food and Beverage Undisputed 01/23/2026 1131827290 CMS
PFIZER INC. $1.63 02/22/2024 Food and Beverage Undisputed 01/23/2026 1131278334 CMS
PFIZER INC. $8.33 02/22/2024 Food and Beverage Undisputed 01/23/2026 1131280637 CMS
PFIZER INC. $1,440.00 05/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1131922039 CMS
PFIZER INC. $109.44 06/26/2024 Food and Beverage Undisputed 01/23/2026 1131473906 CMS
SOBI, INC $31.05 07/15/2024 Food and Beverage Undisputed 01/23/2026 1141420390 CMS
SOBI, INC $18.56 09/17/2024 Food and Beverage Undisputed 01/23/2026 1141424127 CMS
SOBI, INC $89.99 10/15/2024 Education Undisputed 01/23/2026 1141427697 CMS
SOBI, INC $85.00 10/15/2024 Education Undisputed 01/23/2026 1141427703 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.